The medicine was manufactured at Renata’s Bangladesh factory approved by the US-FDA

The drug is manufactured at Renata's factory in Mirpur 

The company announced a cash dividend of 92%, up from the previous year’s 62.5%

The fund will be given as working capital

Renata PLC has begun exporting medicines to the US market, becoming the sixth pharmaceutical manufacturer from Bangladesh to directly ship products to the world's largest market

Shares of the listed drug maker dropped 1.17 percent yesterday from that on the day before to Tk 877